Showing results (211-220 of 381) with videos related to
Sort By:
Pageof 39
Revue D'Epidemiologie Et De Sante Publique|December 10, 2002
[How to choose in practice a model to describe the geographic variation of cancer incidence? Example of gastrointestinal cancers from Côte-d'Or]S David, L Remontet, A M Bouvier, et al.Neurogastroenterology and Motility|November 29, 2016
Rectal intussusception: can high resolution three-dimensional ano-rectal manometry compete with conventional defecography?A Benezech, M Cappiello, K Baumstarck, et al.The Journal of Biological Chemistry|May 5, 1989
Palmitoylation of the human beta 2-adrenergic receptor. Mutation of Cys341 in the carboxyl tail leads to an uncoupled nonpalmitoylated form of the receptorB F O'Dowd, M Hnatowich, M G Caron, et al.European Journal of Clinical Pharmacology|February 10, 2004
Pharmacokinetic modelling of cefotaxime and desacetylcefotaxime--a population study in 25 elderly patientsS Urien, N Laurent, J Barre, et al.The Journal of Biological Chemistry|August 30, 1996
Palmitoylated cysteine 341 modulates phosphorylation of the beta2-adrenergic receptor by the cAMP-dependent protein kinaseS Moffett, L Adam, H Bonin, et al.European Journal of Pharmacology|May 12, 1997
Influence of receptor density on the patterns of beta2-adrenocepter desensitizationG Rousseau, N Guilbault, A Da Silva, et al.Proceedings of the National Academy of Sciences of the United States of America|July 1, 1989
cAMP stimulates transcription of the beta 2-adrenergic receptor gene in response to short-term agonist exposureS Collins, M Bouvier, M A Bolanowski, et al.The British Journal of Surgery|June 29, 2006
Incidence and patterns of recurrence after resection for cure of colonic cancer in a well defined populationS Manfredi, A M Bouvier, C Lepage, et al.The British Journal of Surgery|November 11, 2008
Epidemiology and prognosis of synchronous colorectal cancersM Latournerie, V Jooste, V Cottet, et al.Clinical Rheumatology|December 1, 1992
Serum N terminal procollagen III fragment: a predictive marker of joint destruction in rheumatoid arthritis?J G Tebib, P Viguier, E Noel, et al.Pageof 39